Clinical Trial Update: First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 first-in-patient study update for M201-A Hydrochloride Injection in Japanese patients with paroxysmal atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• M201-A Hydrochloride Injection (M201-A hydrochloride)

Snippet

Sponsor: Kitasato University | Conditions: Paroxysmal Atrial Fibrillation | Phase 2 | Status: UNKNOWN